Dr Olivia Burn received her PhD from the University of Otago under the supervision of Dr Robert Weinkove and within the Cancer Immunotherapy programme at the Malaghan Institute. Her thesis was centred around the innate-like T cell populations natural killer T (NKT) cells and Vγ9Vδ2 T-cells and how these can be harnessed to enhance cancer vaccine effectiveness, with a particular focus on breast cancer.
Dr Burn is currently working as a postdoctoral research fellow in the Hermans Laboratory.
Read more about her research here.
Publications
2021
O K Burn, T E Pankhurst, G F Painter, L M Connor, I F Hermans (2021). Harnessing NKT cells for vaccination. Oxford Open Immunology. 2(1):iqab013